Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà
MedNavigator.ru - Ïîèñê è ïîäáîð ëå÷åíèÿ â Ðîññèè è çà ðóáåæîì

Âåðíóòüñÿ   Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà > Ôîðóìû âðà÷åáíûõ êîíñóëüòàöèé > Ãåìàòîëîãèÿ è òðàíñôóçèîëîãèÿ

Îòâåò
 
Îïöèè òåìû Ïîèñê â ýòîé òåìå Îïöèè ïðîñìîòðà
  #16  
Ñòàðûé 05.03.2021, 22:17
hulk45 hulk45 âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 22.05.2007
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 34
Ñêàçàë(à) ñïàñèáî: 11
hulk45 *
Íóæíà ëè êàêàÿ-òî ïðîôèëàêòèêà? Èëè æèòü êàê æèë è âñå. È íàáëþäàòüñÿ ó âðà÷à. ×òî ñäåëàòü ñ òåìè ñèìïòîìàìè êîòîðûå ìåíÿ ñåé÷àñ áåñïîêîÿò?
Êàêèå åñòü ðåêîìåíäàöèè è òä?
Îòâåòèòü ñ öèòèðîâàíèåì
  #17  
Ñòàðûé 05.03.2021, 22:21
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad íà ôîðóìå
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,345
Ïîáëàãîäàðèëè 33,206 ðàç(à) çà 31,556 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
âñå âîïðîñû - ëå÷. âðà÷àì, åñëè âîçìîæíî, îíè ïðåäëîæàò. ñèìïòîì. òåðàïèþ, ó Âàñ ìîæåò áûòü ðèñê èíôèöèðîâàíèÿ, ìîæåò, íóæíà âàêöèíàöèÿ îò ïíåâìîêîêêà èëè äð.
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #18  
Ñòàðûé 05.03.2021, 23:35
hulk45 hulk45 âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 22.05.2007
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 34
Ñêàçàë(à) ñïàñèáî: 11
hulk45 *
Ó âðà÷à áûëî çàêëþ÷åíèå êîòîðîå ÿ ïðèëîæèë. Ïîëó÷àåòñÿ íóæíî òåïåðü èñêàòü îíêîãåìàòîëîãà?
Îòâåòèòü ñ öèòèðîâàíèåì
  #19  
Ñòàðûé 05.03.2021, 23:41
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad íà ôîðóìå
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,345
Ïîáëàãîäàðèëè 33,206 ðàç(à) çà 31,556 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
ëó÷øå - äà, ìîæåò âàì è íå íóæíî ñåé÷àñ öèòîðåäóêòèâíîå ëå÷åíèå, íî îíè ëó÷øå çíàþò, ÷òî èç äð. ëåêàðñòâ/ìåðîïðèÿòèé åøå ìîæíî/íóæíî ïðè òàêîì äèàãíîçå

Êîììåíòàðèè ê ñîîáùåíèþ:
eduardshraibman îäîáðèë(à):
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #20  
Ñòàðûé 14.03.2021, 10:52
hulk45 hulk45 âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 22.05.2007
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 34
Ñêàçàë(à) ñïàñèáî: 11
hulk45 *
Äîáðûé äåíü. Áûë íà ïðèåìå îíêîãåìàòîëîãà. Àíàëîãè÷íî ñêàçàëè, æäàòü.
Íî ìíå íàïèñàë îäèí î÷åíü èçâåñòíûé ïðîôåññîð èç Èçðàèëÿ.
1. I have no data on your clinical condition and lab results.
2. You sent me results of flow cytometry only. All antigens but CD5 are compatible with CLL, CD5 is very important for diagnosis of classic CLL and in your case is surprisingly low. (may be to repeat later?).
3. Treatment in CLL is administered only with specific indication, not at the time of diagnosis, but when is "no choice" not to treat active disease. Early treatment doesn’t prevent late problems.
4. Unfortunately, it is not true that currently cure in CLL exists, CLL remains to be chronic disease.
5. Up to recent years the standard treatment was immunotherapy that is able to give years of remission. Currently novel agents change the landscape of treatment and some researchers in CLL (more in the USA) already don't use chemotherapy. In my opinion, it is early to conclude that chemotherapy died in CLL. All type of treatment has its benefits and problems.
6. The decision to start treatment and the fact of need for intervention is much more important that the choice of therapy.
7. Important to perform stratification before start of treatment. I hope that in specialized hematology centers in Russia there is a facility to perform genetic test by FISH. Then, if you find chromosome 17p deletion (and probably!!!? 11q deletion), there is no place for chemotherapy, only novel agents should be given. Only several centers (in Israel) perform additional analysis of TP53 mutation status.
8. New data show that IGVH mutation status is also important for the choice of therapy. For cases with Unmutation status novel agents are preferable.
9. I repeat that all these disputes are relevant only at time of indication of therapy and absolutely not before.

×òî ñêàæåòå?
Ìîæåò ñäåëàòü àíàëèç FISH è ìóòàöèþ TP53 . Âåäü ýòî äîëãèå àíàëèçû, êîòîðûå ïðîâîäÿò â òå÷åíèå 2-3 ìåñÿöåâ.
Îòâåòèòü ñ öèòèðîâàíèåì
  #21  
Ñòàðûé 14.03.2021, 12:56
Àâàòàð äëÿ eduardshraibman
eduardshraibman eduardshraibman âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 20.10.2010
Ãîðîä: hadera
Ñîîáùåíèé: 17,873
Ñêàçàë(à) ñïàñèáî: 15
Ïîáëàãîäàðèëè 9,328 ðàç(à) çà 8,902 ñîîáùåíèé
eduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
â çàâèñèìîñòè îò äîñòóïíîñòè, íî ïîêà íà òàêòèêó íå âëèÿåò ðåçóëüòàò.×òî âåðíî íà íàñò.ìîìåíò è ÷òî ïîòâåðäèë èçâåñòíûé ïðîôåññîð : Ëå÷åíèå ïðè ÕËË íàçíà÷àåòñÿ òîëüêî ïî êîíêðåòíûì ïîêàçàíèÿì, íå âî âðåìÿ ïîñòàíîâêè äèàãíîçà, à êîãäà «íåò âûáîðà» íå ëå÷èòü àêòèâíóþ áîëåçíü. Ðàííåå ëå÷åíèå íå ïðåäîòâðàùàåò ïîçäíèõ ïðîáëåì

Êîììåíòàðèè ê ñîîáùåíèþ:
Dr.Vad îäîáðèë(à):
Îòâåòèòü ñ öèòèðîâàíèåì
  #22  
Ñòàðûé 14.03.2021, 15:46
hulk45 hulk45 âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 22.05.2007
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 34
Ñêàçàë(à) ñïàñèáî: 11
hulk45 *
ß äóìàë ÷òî ìîæåò áûòü â áóäóùåì, äàííûå àíàëèçû ïîìîãóò íàçíà÷èòü ïðàâèëüíóþ òàêòèêó ëå÷åíèÿ. À ðåçóëüòàòû èõ æäàòü 2-3 ìåñÿöà. FISH 17p deletion è 11q deletion, TP53 mutation status, IGVH mutation status.
Îòâåòèòü ñ öèòèðîâàíèåì
  #23  
Ñòàðûé 14.03.2021, 17:38
Àâàòàð äëÿ eduardshraibman
eduardshraibman eduardshraibman âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 20.10.2010
Ãîðîä: hadera
Ñîîáùåíèé: 17,873
Ñêàçàë(à) ñïàñèáî: 15
Ïîáëàãîäàðèëè 9,328 ðàç(à) çà 8,902 ñîîáùåíèé
eduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeduardshraibman ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
ñðî÷íîñòè â âûïîëíåíèè àíàëèçîâ íåò.Ñäåëàåòå Âû èõ ñåé÷àñ èëè ÷åðåç 6 ìåñ-â íàñò.âðåìÿ íå âëèÿòåò íà òàêòèêó
Îòâåòèòü ñ öèòèðîâàíèåì
  #24  
Ñòàðûé 23.07.2021, 21:59
hulk45 hulk45 âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 22.05.2007
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 34
Ñêàçàë(à) ñïàñèáî: 11
hulk45 *
Äîáðûé äåíü. Ñàìî÷óâñòâèå óäîâëåòâîðèòåëüíîå.
Áûë â Ìîíèêàõ ã.Ìîñêâà. Ó êëàññíîãî âðà÷à.
Ïîòîì ðåøèë ïîåõàòü íà êîíñóëüòàöèþ â Áîòêèíñêóþ. Òàì òîæå ðàáîòàþò ïðîôè. Âñå â îäèí ãîëîñ ãîâîðÿò ÷òî ëå÷åíèå ïîêà íå òðåáóåòñÿ.

Ìåíÿ áåñïîêîÿò ñëåäóþùèå âîïðîñû. Åñëè åñòü âîçìîæíîñòü ïîìîãèòå ñ îòâåòàìè.
1. ß ãîâîðèë ÷òî ó ìåíÿ áûëî ëå÷åíèå â òóá äèñïàíñåðå.  êîòîðîì ìíå äàëè âûïèñêó ÷òî íåò òóáåðêóë¸çà. Íî äîêòîð ãåìàòîëîã ïîïðîñèëà äàòü âûïèñêó, ÷åì ëå÷èëè.  äèñïàíñåðå ìíå ñêàçàëè ÷òî íóæíî êîíòðîëüíîå ÊÒ ñäåëàòü. Ìíå ãåìàòîëîã äàë íàïðàâëåíèå íà ÏÝÒ ÊÒ. Ðåçóëüòàò Ïýò êò òîò æå áóäåò ÷òî è íà ÊÒ? Ñìîæåò ëè ôòèçèàòð Ïýò êò ñðàâíèòü ñ ïðåäûäóùèì ÊÒ?
2. Ó ìåíÿ ãîä íàçàä âûðåçàëè æèðîâèê. Íî íà ãèñòîëîãèþ íå îòïðàâëÿëè. Ïîêàæåò ëè Ïýò êò îíêî èëè íåò? Êàê ìîæíî ïðîâåðèòü. Âûðåçàëè ïîä ëåâîé ãðóäíîé ìûøöåé. Ïðîñòî ïåðèîäè÷åñêè ýòî ìåñòî òÿíåò.
3. Ïîñëåäíåå âðåìÿ âåíû íà íîãàõ ñòàëè áîëüøå ÷åì îáû÷íî. Èäòè ê ôëåáîëîãó? Ñäåëàòü ÓÇÈ íèæíèõ êîíå÷íîñòåé?
4. Êàñàåìî õëë. ß ÷èòàþ èíîñòðàííûé ôîðóì ïî ÕËË.
Âèæó ÷òî ìíîãèì ïðîïèñûâàþò èáðóòèíèá, ñåé÷àñ òàêæå è àêàëàáðóòèíèá.
Âîîáùå êîãäà íàçíà÷àåòñÿ ëå÷åíèå? Äîêòîð â ìîíèêàõ ãîâîðèëà ÷òî â Ðîññèè ñåé÷àñ ðàñïðîñòðàíåíî ëå÷åíèå ñ ìîíîêëîíàëüíûõ àíòèòåë +ôëóäàðàáèí /öèêëîôîñôàí +ìåòèëïðåä.
Îòâåòèòü ñ öèòèðîâàíèåì
  #25  
Ñòàðûé 23.07.2021, 22:37
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad íà ôîðóìå
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,345
Ïîáëàãîäàðèëè 33,206 ðàç(à) çà 31,556 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Âñå âîïðîñû çàäà¸òå ïðîô. ñïåöèàëèñòàì ïðè ëè÷íîé âñòðå÷å, íà ôîðóìå íåò íè îíêî-ãåìàòîëîãîâ, íè ôòèçèàòðîâ, íè ôëåáîëîãîâ, íà èíîñòðàííûõ ôîðóìàõ èëè ìåæä. îðã. èìåþòñÿ ÷åòêèå êðèòåðèè èíèöèàöèè òåðàïèè,
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
ÿâëÿþòñÿ ëè îíè àíàëîãè÷íûìè â ÐÔ - âîïðîñ âðà÷ó â Ìîíèêè/Áîòêèíàõ. â ÐÔ èìååòñÿ è ïðåäëîæàò òîëüêî òî ëå÷åíèå, êîòîðîå îôèö. çàðåãåíî â ÐÔ, çà íîâåéøèì ëå÷åíèåì -ìàáàìè íóæíî åõàòü â Åâðîïó/Èçðàèëü.
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
Îòâåò



Âàøè ïðàâà â ðàçäåëå
Âû íå ìîæåòå ñîçäàâàòü òåìû
Âû íå ìîæåòå îòâå÷àòü íà ñîîáùåíèÿ
Âû íå ìîæåòå ïðèêðåïëÿòü ôàéëû
Âû íå ìîæåòå ðåäàêòèðîâàòü ñîîáùåíèÿ

BB êîäû Âêë.
Ñìàéëû Âêë.
[IMG] êîä Âêë.
HTML êîä Âûêë.



×àñîâîé ïîÿñ GMT +3, âðåìÿ: 17:28.




Ðàáîòàåò íà vBulletin® âåðñèÿ 3.
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.